|
|
||||||||
Service of Pneumology, Hospital Universitario La Fe, Valencia, Spain
CORRESPONDENCE: R. Menéndez, Servicio de Neumología, Hospital Universitario La Fe, Avda. de Campanar 21, E-46009, Valencia, Spain. Fax: 34 963987397
Keywords: community-acquired pneumonia, length of stay, risk class
Received: October 17, 2000
Accepted March 15, 2001
The total medical costs of community-acquired pneumonia are directly related to the costs of hospital admission and length of stay. The aim of the present study was to evaluate the reasons for prolonged duration of stay in patients stratified in five risk classes for death, and to identify factors associated with prolonged stay.
The study population consisted of 295 patients. According to lower (classes I, II, III) or to higher (classes IV, V) risk, the target duration of hospitalization was set at 5 and 7 days, respectively. The causes of prolonged hospitalization were classified as pneumonia-related, complications, unstable comorbid diseases and nonclinical factors.
The overall percentage of patients with appropriate duration of hospitalization was 32%. Causes of prolonged hospitalization were related mainly to pneumonia (32%) from all risk classes. Morbid complications and instability of the underlying illness were greater in class V patients. Nonclinical factors were present in 29.5% of cases. Hypoxaemia, anaemia, hypoalbuminaemia, and complications appearing before 72 h were associated with prolonged hospitalization.
The cause of prolonged hospitalization of patients with community-acquired pneumonia is multifactorial, depending mainly on pneumonia and comorbid conditions but there is a large number of unnecessary hospitalization days that could be reduced by improving the efficiency of hospital care.
This article has been cited by other articles:
![]() |
J. Beyersmann and M. Schumacher Time-dependent covariates in the proportional subdistribution hazards model for competing risks Biostat., April 22, 2008; (2008) kxn009v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Arnold, J. T. Summersgill, A. S. LaJoie, P. Peyrani, T. J. Marrie, P. Rossi, F. Blasi, P. Fernandez, T. M. File Jr., J. Rello, et al. A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 1086 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M van der Eerden, F Vlaspolder, C S de Graaff, T Groot, W Bronsveld, H M Jansen, and W G Boersma Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study Thorax, August 1, 2005; 60(8): 672 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Menendez, A Torres, R Zalacain, J Aspa, J J Martin Villasclaras, L Borderias, J M Benitez Moya, J Ruiz-Manzano, F Rodriguez de Castro, J Blanquer, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome Thorax, November 1, 2004; 59(11): 960 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Menendez, M.J. Cremades, E. Martinez-Moragon, J.J. Soler, S. Reyes, and M. Perpina Duration of length of stay in pneumonia: influence of clinical factors and hospital type Eur. Respir. J., October 1, 2003; 22(4): 643 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.P. Espana, A. Capelastegui, J.M. Quintana, A. Soto, I. Gorordo, M. Garcia-Urbaneja, and A. Bilbao A prediction rule to identify allocation of inpatient care in community-acquired pneumonia Eur. Respir. J., April 1, 2003; 21(4): 695 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Menendez, D. Ferrando, J. M. Valles, and J. Vallterra Influence of Deviation From Guidelines on the Outcome of Community-Acquired Pneumonia* Chest, August 1, 2002; 122(2): 612 - 617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |